Homepage | CIDRAP
WEBCIDRAP Merchandise. CIDRAP and Osterholm Update podcast merchandise is available for purchase. Order t-shirts, mugs, socks, buttons, stickers, and more!
Remdesivir plus dexamethasone tied to lower COVID death rate
WEB8 hours ago · A new study of outcomes among more than 33,000 hospitalized COVID-19 patients shows that remdesivir plus dexamethasone administration is associated with lower mortality rates at 14 and 28 days compared with dexamethasone alone, according to findings in Clinical Infectious Diseases. The retrospective, comparative effectiveness study used data on ...
COVID-19 - CIDRAP
WEBNew report: COVID more severe, longer-lasting than other respiratory diseases. COVID-19 participants most often reported fatigue, muscle aches, headache, and loss of taste and/or smell, consistent with the more extensive systemic COVID-19 effects. Mary Van Beusekom.
Poll: Only 45% of older adults will get updated COVID vaccines
WEB11 hours ago · Topics. COVID-19. Only 45% of Americans age 50 and older say they're likely to get the updated COVID-19 vaccine this season, according to a poll today from the University of Michigan. The poll shows many at high risk of severe illness appear unlikely to seek the vaccine, and interest in an updated vaccine varies widely by age-group, education ...
About CIDRAP | CIDRAP
WEBThe Center for Infectious Disease Research and Policy (CIDRAP; "SID-wrap") is a global leader in addressing public health preparedness and emerging infectious disease response. Founded in 2001, CIDRAP is part of the Research and Innovation Office at the University of Minnesota. CIDRAP works to prevent illness and death from targeted infectious ...
MRSA - CIDRAP
WEBHospitalization linked to higher risk of MRSA infections in households. Researchers found household exposure to a recently hospitalized family member increased the chances of getting a methicillin-resistant Staphylococcus aureus infection by 44%. Chris Dall.
CIDRAP in the News
WEBAug 15, 2024 In Foreign Affairs, Director Michael Osterholm, PhD, MPH, and coauthor Mark Olshaker discuss how governments and international organizations have done far too little to prepare for the next pandemic-causing virus.. Jul 2, 2024 CIDRAP releases two new Research and Development Roadmaps: one for developing tools to combat Nipah virus and the other for tools to combat Lassa fever.
A 'very solvable' problem: Steps needed to tackle global ... - CIDRAP
WEB10 hours ago · But Laxminarayan remains optimistic that the world can tackle what he believes is a solvable problem by focusing on infection prevention and antibiotic access, particularly in the low- and middle-income countries (LMICs) where AMR has become a substantial cause of morbidity and mortality. CIDRAP News recently spoke with Laxminarayan about the ...
COVID-19: CIDRAP Commentaries
WEBCOVID-19: The CIDRAP Viewpoint. Starting at the beginning of the pandemic, CIDRAP compiled a groundbreaking of series of reports on key aspects of COVID-19, such as what direction the pandemic might take, how to communicate risks effectively, smart testing for the virus and for antibodies to it, contact tracing, surveillance, ensuring a ...
COVID-19: The CIDRAP Viewpoint
WEBApr 30, 2020 · Part 1: The Future of the COVID-19 Pandemic: Lessons Learned from Pandemic Influenza. Kristine A. Moore, MD, MPH; Marc Lipsitch, DPhil; John M. Barry, MA; Michael T ...